Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19

Juan Du, Lirong Wei, Guoli Li, Mingxi Hua, Yao Sun, Di Wang, Kai Han, Yonghong Yan, Chuan Song, Rui Song, Henghui Zhang, Junyan Han, Jingyuan Liu, Yaxian KongFrontiers in Immunology 2021 · DOI

Abstract

Our findings indicated that HLA-DR<sup>+</sup>CD38<sup>hi</sup> CD8<sup>+</sup> T cells were correlated with disease severity of COVID-19 rather than HLA-DR<sup>+</sup>CD38<sup>dim</sup> population.

Introduction

Early in the COVID-19 pandemic, clinicians observed a paradoxical immune state in severe patients: a drastic reduction in total T cells (lymphopenia) alongside high activation markers (HLA-DR and CD38) on the remaining cells. This study investigates whether these activated CD8+ T cells are beneficial or detrimental, specifically by distinguishing between different intensities of CD38 expression to identify biomarkers for disease progression.

Methods and Materials

Researchers conducted a retrospective longitudinal study of 42 COVID-19 patients (32 mild/moderate, 10 severe/critical) at Beijing Ditan Hospital, compared against 20 healthy donors (HD).

  • Flow Cytometry: Used to categorize T cell subsets based on HLA-DR and CD38 expression levels.
  • Multiplex Assays: Measured 45 cytokines/chemokines and 14 soluble immune checkpoints.
  • Transcriptional Profiling: Analyzed transcription factors (T-bet, Eomes) to assess cell exhaustion.
  • Clinical Correlation: Mapped T cell percentages against markers of organ damage (LDH, AST, Creatinine) and systemic inflammation (CRP, SAA).

Key Insights: Functional Dysregulation

The study reveals a critical distinction between HLA-DR⁺CD38dim and HLA-DR⁺CD38hi CD8⁺ T cells. While the "dim" population represents a standard functional immune response, the "high" population signifies immune dysregulation.

  • Exhaustion Profile: CD38hi cells exhibited higher levels of inhibitory checkpoints (PD-1, TIM-3, LAG-3) and a transcriptional profile (T-bet^dim Eomes^hi) characteristic of terminal exhaustion.
  • Pro-apoptotic State: These cells showed increased expression of BAX and decreased Bcl-2, suggesting they are prone to programmed cell death, contributing to systemic lymphopenia.
  • Impaired Cytotoxicity: Despite containing granzyme B and perforin, their actual "killing potential" was diminished compared to the CD38dim subset.

Results and Clinical Significance

The percentage of HLA-DR⁺CD38hi CD8⁺ T cells serves as a robust biomarker for disease severity. In severe cases, these cells peaked at approximately 23.5% of the CD8⁺ population, whereas they only reached 3.2% in mild cases.

Figure 1: Comparison of HLA-DR+CD38+ CD8+ T cell subsets (I, II, III) across healthy donors (HD), mild/moderate (M/M), and severe/critical (S/C) COVID-19 patients. Panel A shows gating; Panel B shows statistical differences; Panels C and D show longitudinal persistence.

Furthermore, the persistence of these cells was markedly different; they declined rapidly in mild cases but remained elevated for weeks in severe patients. This subset showed a strong positive correlation with Lactate Dehydrogenase (LDH) (R=0.643, P<0.0001), indicating a direct link between this overactivated immune state and physical tissue injury.

Discussion and Limitations

While these findings identify a specific cellular biomarker for severe COVID-19, the study is limited by its small sample size (n=42). Additionally, the lack of direct in vitro functional assays means the "impaired killing" is inferred from molecular markers. Future research is required to determine if these cells are a cause of tissue damage or a secondary symptom of overwhelming inflammation, potentially opening doors for targeted immunotherapies.

Summary updated

Abstract

Our findings indicated that HLA-DR<sup>+</sup>CD38<sup>hi</sup> CD8<sup>+</sup> T cells were correlated with disease severity of COVID-19 rather than HLA-DR<sup>+</sup>CD38<sup>dim</sup> population.
BibTeX
@inproceedings{du2021persistent,
  author = {Juan Du and Lirong Wei and Guoli Li and Mingxi Hua and Yao Sun and Di Wang and Kai Han and Yonghong Yan and Chuan Song and Rui Song and Henghui Zhang and Junyan Han and Jingyuan Liu and Yaxian Kong},
  title = {{Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.735125},
}
Figure